|
Index of reports
> Cases with Sepsis (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Lorazepam; Mitoxantrone; Morphine Sulfate; Neupogen; Etoposide; Cytarabine; Hydrocodone Bitartrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Etoposide; Cytarabine; Mitoxantrone; Hydrocodone; Neupogen; Morphine; Lorazepam
Possible Mozobil side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 56 year old male
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Mitoxantrone; Cytarabine; Granulocyte Colony Stimulating Factor; Etoposide
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-03-20
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Respiratory Failure, Sepsis, Haemorrhage Intracranial
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Platelets; Neupogen
Possible Mozobil side effects in 39 year old female
Reported by a pharmacist from South Africa on 2012-03-15
Patient: 39 year old female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: 20 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Mozobil
Indication: non-Hodgkin's Lymphoma
Possible Mozobil side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-02
Patient:
Reactions: Therapeutic Response Decreased, Sepsis
Drug(s) suspected as cause:
Mozobil
Indication: Multiple Myeloma
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
|
